AAAAAA
Results: 1-25/26
Authors:
LAHTI RA
ROBERTS RC
COCHRANE EV
PRIMUS RJ
GALLAGER DW
CONLEY RR
TAMMINGA CA
Citation: Ra. Lahti et al., DIRECT DETERMINATION OF DOPAMINE D-4 RECEPTORS IN NORMAL AND SCHIZOPHRENIC POSTMORTEM BRAIN-TISSUE - A [H-3]NGD-94-1 STUDY, Molecular psychiatry, 3(6), 1998, pp. 528-533
OLANZAPINE RESPONSE IN TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS WITH A HISTORY OF SUBSTANCE-ABUSE
Authors:
CONLEY RR
KELLY DL
GALE EA
Citation: Rr. Conley et al., OLANZAPINE RESPONSE IN TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS WITH A HISTORY OF SUBSTANCE-ABUSE, Schizophrenia research, 33(1-2), 1998, pp. 95-101
Authors:
LAHTI RA
COCHRANE EV
ROBERTS RC
CONLEY RR
TAMMINGA CA
Citation: Ra. Lahti et al., [H-3]NEUROTENSIN RECEPTOR DENSITIES IN HUMAN POSTMORTEM BRAIN-TISSUE OBTAINED FROM NORMAL AND SCHIZOPHRENIC PERSONS - AN AUTORADIOGRAPHIC STUDY, Journal of neural transmission, 105(4-5), 1998, pp. 507-516
Authors:
CONLEY RR
Citation: Rr. Conley, OPTIMIZING TREATMENT WITH CLOZAPINE, The Journal of clinical psychiatry, 59, 1998, pp. 44-48
Authors:
CONLEY RR
TAMMINGA CA
BARTKO JJ
RICHARDSON C
PESZKE M
LINGLE J
HEGERTY J
LOVE R
GOUNARIS C
ZAREMBA S
Citation: Rr. Conley et al., OLANZAPINE COMPARED WITH CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA, The American journal of psychiatry, 155(7), 1998, pp. 914-920
Authors:
CONLEY RR
TAMMINGA CA
BEASLEY C
Citation: Rr. Conley et al., OLANZAPINE VS CHLORPROMAZINE IN THERAPY-REFRACTORY SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 190-190
Authors:
CONLEY RR
ZAREMBA S
MCMULLEN R
LOVE R
Citation: Rr. Conley et al., EVALUATING ABILITY TO CONSENT IN PSYCHOTIC INPATIENTS, Schizophrenia research, 24(1-2), 1997, pp. 206-206
Authors:
CONLEY RR
BUCHANAN RW
Citation: Rr. Conley et Rw. Buchanan, EVALUATION OF TREATMENT-RESISTANT SCHIZOPHRENIA, Schizophrenia bulletin, 23(4), 1997, pp. 663-674
Authors:
PANDEY GN
DWIVEDI Y
PANDEY SC
CONLEY RR
ROBERTS RC
TAMMINGA CA
Citation: Gn. Pandey et al., PROTEIN-KINASE-C IN THE POSTMORTEM BRAIN OF TEENAGE SUICIDE VICTIMS, Neuroscience letters, 228(2), 1997, pp. 111-114
Authors:
DECKELMAN MC
DIXON LB
CONLEY RR
Citation: Mc. Deckelman et al., COMORBID BULIMIA-NERVOSA AND SCHIZOPHRENIA, The International journal of eating disorders, 22(1), 1997, pp. 101-105
Authors:
PANDEY GN
CONLEY RR
PANDEY SC
GOEL S
ROBERTS RC
TAMMINGA CA
CHUTE D
SMIALEK J
Citation: Gn. Pandey et al., BENZODIAZEPINE RECEPTORS IN THE POSTMORTEM BRAIN OF SUICIDE VICTIMS AND SCHIZOPHRENIC SUBJECTS, Psychiatry research, 71(3), 1997, pp. 137-149
Authors:
TAMMINGA CA
CONLEY RR
Citation: Ca. Tamminga et Rr. Conley, THE APPLICATION OF NEUROIMAGING TECHNIQUES TO DRUG DEVELOPMENT, The Journal of clinical psychiatry, 58, 1997, pp. 3-6
Authors:
CONLEY RR
TAMMINGA CA
Citation: Rr. Conley et Ca. Tamminga, OLANZAPINE VS. CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA, Psychopharmacology bulletin, 33(3), 1997, pp. 471-471
Authors:
CONLEY RR
TAMMINGA CA
BEASLEY C
Citation: Rr. Conley et al., OLANZAPINE VS CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA, Biological psychiatry, 41, 1997, pp. 246-246
Authors:
CONLEY RR
CARPENTER WT
TAMMINGA CA
Citation: Rr. Conley et al., TIME TO CLOZAPINE RESPONSE IN A STANDARDIZED TRIAL, The American journal of psychiatry, 154(9), 1997, pp. 1243-1247
Authors:
LAHTI RA
ROBERTS RC
CONLEY RR
COCHRANE EV
MUTIN A
TAMMINGA CA
Citation: Ra. Lahti et al., D-2-TYPE DOPAMINE-RECEPTORS IN POSTMORTEM HUMAN BRAIN SECTIONS FROM NORMAL AND SCHIZOPHRENIC SUBJECTS, NeuroReport, 7(12), 1996, pp. 1945-1948
Authors:
LAHTI RA
ROBERTS RC
CONLEY RR
TAMMINGA CA
Citation: Ra. Lahti et al., DOPAMINE D-2, D-3, D-4 RECEPTORS IN HUMAN POSTMORTEM BRAIN SECTIONS -COMPARISON BETWEEN NORMALS AND SCHIZOPHRENICS, Schizophrenia research, 18(2-3), 1996, pp. 1-1
Authors:
CONLEY RR
LOVE R
Citation: Rr. Conley et R. Love, EVALUATING ABILITY TO CONSENT IN PSYCHOTIC INPATIENTS, Psychopharmacology bulletin, 32(3), 1996, pp. 392-392
Authors:
CARPENTER WT
CONLEY RR
BUCHANAN RW
BREIER A
TAMMINGA CA
Citation: Wt. Carpenter et al., CLOZAPINE CONFLICT, The American journal of psychiatry, 153(11), 1996, pp. 1505-1507
Authors:
DAVISS SR
CONLEY RR
Citation: Sr. Daviss et Rr. Conley, DENSITY AND DISTRIBUTION OF LABELED SUBPOPULATIONS OF MEDIODORSAL THALAMIC NEURONS IN SCHIZOPHRENIC AND CONTROL SUBJECTS, Schizophrenia research, 15(1-2), 1995, pp. 27-27
Authors:
PANDEY GN
PANDEY SC
CONLEY RR
ROBERTS R
TAMMINGA CA
Citation: Gn. Pandey et al., BENZODIAZEPRINE RECEPTORS IN HUMAN POSTMORTEM BRAIN - EFFECT OF SCHIZOPHRENIA, SUICIDE, AND NEUROLEPTIC DRUG-TREATMENT, Schizophrenia research, 15(1-2), 1995, pp. 68-68
Authors:
CARPENTER WT
CONLEY RR
BUCHANAN RW
BREIER A
TAMMINGA CA
Citation: Wt. Carpenter et al., PATIENT RESPONSE AND RESOURCE-MANAGEMENT - ANOTHER VIEW OF CLOZAPINE TREATMENT OF SCHIZOPHRENIA, The American journal of psychiatry, 152(6), 1995, pp. 827-832
Authors:
TAMMINGA CA
CONLEY RR
WONG DF
Citation: Ca. Tamminga et al., HUMAN BRAIN RECEPTORS .4. HUMAN IN-VIVO RECEPTOR IMAGING, The American journal of psychiatry, 151(5), 1994, pp. 639-639
Authors:
HOLCOMB HH
CASCELLA NG
MEDOFF DR
GASTINEAU EA
LOATS H
THAKER GK
CONLEY RR
DANNALS RF
WAGNER HN
TAMMINGA CA
Citation: Hh. Holcomb et al., PET-FDG TEST-RETEST RELIABILITY DURING A VISUAL-DISCRIMINATION TASK IN SCHIZOPHRENIA, Journal of computer assisted tomography, 17(5), 1993, pp. 704-709
Authors:
CONLEY RR
GOUNARIS CJ
WONG DF
TAMMINGA CT
Citation: Rr. Conley et al., CLOZAPINE VS HALOPERIDOL DOPAMINE RECEPTOR OCCUPANCY IN SCHIZOPHRENIABY C-11 NMSP PET, Biological psychiatry, 33(6A), 1993, pp. 59-59